AHRQ Comparative Research Agenda Will Start With Rx Drugs
Executive Summary
The Agency for Healthcare Research & Quality is recommending that its initial list of priorities for comparative effectiveness research should focus on prescription drugs
You may also be interested in...
AHRQ Outcomes Research Should Focus On Diseases, Not Drugs – PhRMA
Comparative cost-effectiveness research sponsored by the Agency for Healthcare Research & Quality should focus on treatment options rather than comparing drug classes, the Pharmaceutical Research & Manufacturers of America suggested
AHRQ Outcomes Research Should Focus On Diseases, Not Drugs – PhRMA
Comparative cost-effectiveness research sponsored by the Agency for Healthcare Research & Quality should focus on treatment options rather than comparing drug classes, the Pharmaceutical Research & Manufacturers of America suggested
Large Comparative Trials Deserve More Support, FDAer Says
Thrombolytic agent mortality studies demonstrate the value of large head-to-head trials to detect small outcomes differences between drugs, Center for Drug Evaluation & Research Acting Deputy Director Mark Goldberger said